Anne‐Marie Lambeir

9.4k total citations · 1 hit paper
177 papers, 7.8k citations indexed

About

Anne‐Marie Lambeir is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anne‐Marie Lambeir has authored 177 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 69 papers in Molecular Biology and 67 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anne‐Marie Lambeir's work include Peptidase Inhibition and Analysis (94 papers), Neuropeptides and Animal Physiology (65 papers) and Diabetes Treatment and Management (23 papers). Anne‐Marie Lambeir is often cited by papers focused on Peptidase Inhibition and Analysis (94 papers), Neuropeptides and Animal Physiology (65 papers) and Diabetes Treatment and Management (23 papers). Anne‐Marie Lambeir collaborates with scholars based in Belgium, United States and Canada. Anne‐Marie Lambeir's co-authors include Ingrid De Meester, Simon Scharpé, Christine Durinx, Koen Augustyns, Pieter Van der Veken, Achiel Haemers, Jurgen Joossens, Paul Proost, H. Brian Dunford and Rik K. Wierenga and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Anne‐Marie Lambeir

176 papers receiving 7.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

2003 809 citations Anne‐Marie Lambeir, Christine Durinx et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne‐Marie Lambeir Belgium	47	3.8k	3.1k	2.0k	1.5k	897	177	7.8k
Koen Augustyns Belgium	45	2.4k 0.7×	2.9k 0.9×	1.3k 0.6×	763 0.5×	539 0.6×	206	6.7k
Lucia Altucci Italy	62	2.1k 0.6×	9.9k 3.2×	486 0.2×	500 0.3×	541 0.6×	321	14.5k
Udo Oppermann United Kingdom	65	1.7k 0.5×	8.8k 2.9×	239 0.1×	1.6k 1.1×	755 0.8×	241	13.8k
Torsten Hoffmann Germany	34	1.2k 0.3×	3.5k 1.1×	933 0.5×	578 0.4×	243 0.3×	105	6.1k
Richard Béliveau Canada	59	3.4k 0.9×	5.8k 1.9×	528 0.3×	229 0.2×	830 0.9×	274	12.0k
Ildo Nicoletti Italy	37	1.9k 0.5×	6.9k 2.3×	367 0.2×	469 0.3×	455 0.5×	101	11.6k
Kazuo Umezawa Japan	51	2.1k 0.6×	5.3k 1.7×	270 0.1×	547 0.4×	906 1.0×	425	11.0k
Claudio Arra Italy	47	1.6k 0.4×	3.5k 1.2×	360 0.2×	478 0.3×	333 0.4×	162	6.5k
Yuqin Wang China	47	1.3k 0.3×	3.8k 1.3×	258 0.1×	446 0.3×	1.9k 2.1×	271	7.4k
Elias Lolis United States	42	1.0k 0.3×	2.0k 0.7×	1.5k 0.7×	632 0.4×	698 0.8×	108	6.9k

Countries citing papers authored by Anne‐Marie Lambeir

Since Specialization

Citations

This map shows the geographic impact of Anne‐Marie Lambeir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Marie Lambeir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Marie Lambeir more than expected).

Fields of papers citing papers by Anne‐Marie Lambeir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Marie Lambeir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Marie Lambeir. The network helps show where Anne‐Marie Lambeir may publish in the future.

Co-authorship network of co-authors of Anne‐Marie Lambeir

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Marie Lambeir. A scholar is included among the top collaborators of Anne‐Marie Lambeir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Marie Lambeir. Anne‐Marie Lambeir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boisseau, William, Lucas Di Meglio, Stéphane Loyau, et al.. (2020). Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke. Journal of Thrombosis and Haemostasis. 18(12). 3325–3335. 6 indexed citations

Moons, Rani, et al.. (2020). Effects of Detergent on α-Synuclein Structure: A Native MS-Ion Mobility Study. International Journal of Molecular Sciences. 21(21). 7884–7884. 13 indexed citations

Rompaey, Dries Van, et al.. (2019). Efforts towards an On‐Target Version of the Groebke–Blackburn–Bienaymé (GBB) Reaction for Discovery of Druglike Urokinase (uPA) Inhibitors. Chemistry - A European Journal. 25(53). 12380–12393. 12 indexed citations

Ceuleers, Hannah, Nikita Hanning, Jurgen Joossens, et al.. (2018). Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome. British Journal of Pharmacology. 175(17). 3516–3533. 36 indexed citations

Ceuleers, Hannah, Jurgen Joossens, Koen Augustyns, et al.. (2017). Regulation of intestinal permeability: The role of proteases. World Journal of Gastroenterology. 23(12). 2106–2106. 139 indexed citations

Tsirigotaki, Alexandra, Roos Van Elzen, Pieter Van der Veken, Anne‐Marie Lambeir, & Anastassios Economou. (2017). Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry. Scientific Reports. 7(1). 2456–2456. 20 indexed citations

Lanckacker, Ellen, Nadia Zakaria, Carina Koppen, et al.. (2016). Optimization and validation of an existing, surgical and robust dry eye rat model for the evaluation of therapeutic compounds. Experimental Eye Research. 146. 172–178. 15 indexed citations

Jansen, Koen, Hans De Winter, Jurgen Joossens, et al.. (2015). Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation. MedChemComm. 7(3). 433–438. 8 indexed citations

Jansen, Koen, Jonathan D. Cheng, Jurgen Joossens, et al.. (2013). Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold. ACS Medicinal Chemistry Letters. 4(5). 491–496. 194 indexed citations

10.

Lambeir, Anne‐Marie, et al.. (2013). The potential of carboxypeptidase M as a therapeutic target in cancer. Expert Opinion on Therapeutic Targets. 17(3). 265–279. 23 indexed citations

11.

Veken, Pieter Van der, Véronique Dubois, Anne‐Marie Lambeir, et al.. (2008). Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: Isoindoline containing inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4159–4162. 62 indexed citations

12.

Brandt, Inger, Melanie Gérard, Kjell Sergeant, et al.. (2008). Prolyl oligopeptidase stimulates the aggregation of α-synuclein. Peptides. 29(9). 1472–1478. 76 indexed citations

13.

Deiteren, Kathleen, Dirk Hendriks, Simon Scharpé, & Anne‐Marie Lambeir. (2008). Carboxypeptidase M: Multiple alliances and unknown partners. Clinica Chimica Acta. 399(1-2). 24–39. 41 indexed citations

14.

Maes, Marie-Berthe, Wim Martinet, D. Schrijvers, et al.. (2006). Dipeptidyl peptidase II and leukocyte cell death. Biochemical Pharmacology. 72(1). 70–79. 15 indexed citations

15.

Augustyns, Koen, et al.. (1999). ChemInform Abstract: The Unique Properties of Dipeptidyl‐Peptidase IV (DPP IV / CD26) and the Therapeutic Potential of DPP IV Inhibitors. ChemInform. 30(29). 1 indexed citations

16.

Proost, Paul, Ingrid De Meester, Dominique Schols, et al.. (1998). Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV. Journal of Biological Chemistry. 273(13). 7222–7227. 226 indexed citations

17.

Meester, Ingrid De, Anne‐Marie Lambeir, А. М. Belyaev, et al.. (1996). IN VIVO INHIBITION OF DIPEPTIDYL PEPTIDASE IV (DPP IV) BY PRO-PRO-DIPHENYL PHOSPHONATE (DIPROFEN). Biochemical Society Transactions. 24(4). 630S–630S. 3 indexed citations

18.

Stassen, JM, Hans Deckmyn, Ingrid Vreys, & Anne‐Marie Lambeir. (1993). Comparative properties of a factor-xa inhibitor, 4c2 (an aprotonin analog), heparin and hirudin in a hamster femoral vein platelet-rich mural thrombosis model. Thrombosis and Haemostasis. 69(6). 588–588. 2 indexed citations

19.

Wierenga, Rik K., et al.. (1989). Glucosephosphate isomerase from Trypanosoma brucei. European Journal of Biochemistry. 184(2). 455–464. 94 indexed citations

20.

Lambeir, Anne‐Marie, et al.. (1983). A Quantitatiove Desdcription of Microtubule Formadtion in the Presence of Tubulin-Colchicine. European Journal of Biochemistry. 132(2). 369–373. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact